Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

406 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Mast cell blocking reduces brain edema and hematoma volume and improves outcome after experimental intracerebral hemorrhage.
Strbian D, Tatlisumak T, Ramadan UA, Lindsberg PJ. Strbian D, et al. Among authors: tatlisumak t. J Cereb Blood Flow Metab. 2007 Apr;27(4):795-802. doi: 10.1038/sj.jcbfm.9600387. Epub 2006 Aug 16. J Cereb Blood Flow Metab. 2007. PMID: 16926842
Effect of basic fibroblast growth factor on experimental focal ischemia studied by diffusion-weighted and perfusion imaging.
Tatlisumak T, Takano K, Carano RA, Fisher M. Tatlisumak T, et al. Stroke. 1996 Dec;27(12):2292-7; discussion 2298. doi: 10.1161/01.str.27.12.2292. Stroke. 1996. PMID: 8969796
Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats.
Onal MZ, Li F, Tatlisumak T, Locke KW, Sandage BW Jr, Fisher M. Onal MZ, et al. Among authors: tatlisumak t. Stroke. 1997 May;28(5):1060-5. doi: 10.1161/01.str.28.5.1060. Stroke. 1997. PMID: 9158650

Mean infarct volume in animals dying prematurely was significantly (P < .05, Student's t test) larger in group 1 than those surviving for 7 days (247.2 +/- 89.5 versus 139.2 +/- 68.2 mm3), but there was no significant difference in infarct volume in groups 2, 3, and 4 b

Mean infarct volume in animals dying prematurely was significantly (P < .05, Student's t test) larger in group 1 than those surviv

Glycine site antagonist attenuates infarct size in experimental focal ischemia. Postmortem and diffusion mapping studies.
Takano K, Tatlisumak T, Formato JE, Carano RA, Bergmann AG, Pullan LM, Bare TM, Sotak CH, Fisher M. Takano K, et al. Among authors: tatlisumak t. Stroke. 1997 Jun;28(6):1255-62; discussion 1263. doi: 10.1161/01.str.28.6.1255. Stroke. 1997. PMID: 9183359
A glycine site antagonist, ZD9379, reduces number of spreading depressions and infarct size in rats with permanent middle cerebral artery occlusion.
Tatlisumak T, Takano K, Meiler MR, Fisher M. Tatlisumak T, et al. Stroke. 1998 Jan;29(1):190-5. doi: 10.1161/01.str.29.1.190. Stroke. 1998. PMID: 9445350
A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: a diffusion and perfusion MRI study.
Tatlisumak T, Carano RA, Takano K, Opgenorth TJ, Sotak CH, Fisher M. Tatlisumak T, et al. Stroke. 1998 Apr;29(4):850-7; discussion 857-8. doi: 10.1161/01.str.29.4.850. Stroke. 1998. PMID: 9550522
Delayed treatment with an adenosine kinase inhibitor, GP683, attenuates infarct size in rats with temporary middle cerebral artery occlusion.
Tatlisumak T, Takano K, Carano RA, Miller LP, Foster AC, Fisher M. Tatlisumak T, et al. Stroke. 1998 Sep;29(9):1952-8. doi: 10.1161/01.str.29.9.1952. Stroke. 1998. PMID: 9731623
Bilateral sphenoid wing metastases of prostate cancer presenting with extensive brain edema.
Lindsberg PJ, Tatlisumak T, Tienari J, Brander A. Lindsberg PJ, et al. Among authors: tatlisumak t. Eur J Neurol. 1999 May;6(3):363-6. doi: 10.1046/j.1468-1331.1999.630363.x. Eur J Neurol. 1999. PMID: 10210920
[New applications of magnetic nuclear imaging in the detection of acute cerebral ischemia].
Tatlisumak T, Lahti K, Valanne L, Kaste M. Tatlisumak T, et al. Duodecim. 1996;112(15):1333-7. Duodecim. 1996. PMID: 10596112 Review. Finnish. No abstract available.
Plasma endothelin-1 levels neither increase nor correlate with neurological scores, stroke risk factors, or outcome in patients with ischemic stroke.
Haapaniemi E, Tatlisumak T, Hamel K, Soinne L, Lanni C, Opgenorth TJ, Kaste M. Haapaniemi E, et al. Among authors: tatlisumak t. Stroke. 2000 Mar;31(3):720-5. doi: 10.1161/01.str.31.3.720. Stroke. 2000. PMID: 10700510
406 results
Jump to page
Feedback